US$ 21.11
fda tirzepatide injection shortage resolved october 2 2024 GLP-1 Drugs: Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug List FDA says shortage of GLP-1
Description
The compound keeps the muscle on and the nausea away

Missing one dose has minimal impact if you resume your regular schedule the following week

The most frequent problems were stomach-related issues like nausea, vomiting, diarrhea, and a reduced appetite
Vitastir has been amazing and so far I havent had to wait more than a few days to receive my order

In fertility and early embryonic development studies, male and female rats were administered twice weekly subcutaneous doses of 0.5, 1.5, or 3 mg/kg (0.3-, 1-, and 2-fold and 0.3-, 0.9-, and 2-fold, respectively, the MRHD of 15 mg once weekly based on AUC)
